Health Technologies

This Institute coordinates research in the field of technologies that are essential to biomedical progress in both fundamental and clinical terms.

Scientific and industrial challenges

The Institute adopts a transdisciplinary and translational approach, bringing into contact, upstream, researchers and engineers from very different domains (mathematics, physics, chemistry, biology, IT, electronics, nanotechnology, etc.) and downstream physicians and manufacturers.

Each field has its own challenges:

ImagingThe main challenges are to increase the sensitivity and definition of the images obtained, speed up data analysis, improve image reconstruction and reduce the doses of radiation emitted to patients for radiation examinations.

Drugs The challenges here include improving screening effectiveness, evaluating the toxicity and bioavailability of possible drugs early on, and simplifying and accelerating the time it takes for drugs to be developed.

Biotechnologies, bioengineeringOne of the major objectives is to develop early diagnostic tests, in vitro and in vivo, which are specific to and reproducible for new diseases or diseases for which diagnosis is currently at too late a stage.

Surgery and interventional techniquesThe main breakthroughs will particularly focus on the reliability, biocompatibility and performances of these technologies, miniaturization and automation of interventional tools, and software programs that create images of the operation sites.



Actualités de l'Itmo_Santé publique


Medical challenges

Identifying risk factors associated with diseases, making diagnoses sooner, improving treatment efficacy with account taken of patient comfort … these are just some of the challenges involved in developing better disease prevention and treatment.Beyond essential knowledge of physiology and human diseases, new technological approaches can also make a significant contribution to medical progress. Such progress results today from a close working partnership between researchers and engineers, biologists and physicians.

In full development, these health technologies can be split into four main areas.

  • ImagingThis covers all anatomical and functional, cellular and molecular imaging technologies both in vitro and in vivo.
  • DrugsNew drugs emerge only after a long and expensive process, beginning with the screening of thousands of molecules and ending with possible marketing.
  • Biotechnologies, bioengineeringThis field encompasses all in vitro analytical and diagnostic technologies, their implantation in the living organism and biomaterials linked to regenerative medicine and bio-production.
  • Surgery and interventional techniquesSurgical technologies include a wide range of methods and expertise with the fundamental purpose of minimizing risks of complication for the patient and reducing intervention and hospitalization time.


Director : Franck Lethimonnier

Deputy Director : Yves Remond

Director's assistants: Inês Amado, Corinne Sebastiani

Policy Officers: Marco Fiorini, Marie-Thérèse Ménager

View Edit Create here